Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | President, Americas | March 20, 2018 | March 22, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date March 20, 2018 · Filed March 22, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.44 · Expires 2028-03-20 | Direct | 20,375 |
Reported balance
After 2018-03-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-20 · Grant · Acquired 20,375 · Balance 20,375 F1: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2018 Filed Mar 22, 2018 20:10 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 20,375 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000066 · edgar.xml · derivative · entry 1 Delp Robert D. · CIK 0001696948 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,375 Underlying: Common Stock · 20,375 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 21,565 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000041 · edgar.xml · derivative · entry 1 Delp Robert D. · CIK 0001696948 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,565 Underlying: Common Stock · 21,565 shares Expires 2028-02-20 Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:56 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 14,535 | $0.00 Strike: $121.88 | $0.00 |
DisclosureSEC source: 0000911916-17-000119 · edgar.xml · derivative · entry 1 Delp Robert D. · CIK 0001696948 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,535 Underlying: Common Stock · 14,535 shares Expires 2027-03-21 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.